% | $
Quotes you view appear here for quick access.

Kinder Morgan Energy Partners Message Board

kmclaurin 1 post  |  Last Activity: Jan 30, 2016 5:27 PM Member since: Mar 27, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • kmclaurin by kmclaurin Jan 30, 2016 5:27 PM Flag

    Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE® (dalbavancin)
    - Single-Dose Option Approved for Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
    Another $1 per share for those of us who held Durata before it was acquired. Another $3 per share was possible depending on the sales totals for Dalvance. But I never saw any specific numbers mentioned.